Showing results (1-10 of 385) with videos related to
Sort By:
Pageof 39
Expert Review of Neurotherapeutics|February 25, 2015
Neuroprotection in ischemic stroke: what does the future hold?Amos D Korczyn, Michael Brainin, Alla GuekhtNeurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 30, 2014
Diabetes and the brain: issues and unmet needsNatan M Bornstein, Michael Brainin, Alla Guekht, et al.Journal of the Neurological Sciences|April 5, 2012
Neuroprotection in vascular dementia: a future pathIngmar Skoog, Amos D Korczyn, Alla GuekhtStroke|April 23, 2017
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive ImpairmentAlla Guekht, Ingmar Skoog, Sally Edmundson, et al.Dementia and Geriatric Cognitive Disorders Extra|February 12, 2014
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study DesignAlla Guekht, Ingmar Skoog, Amos D Korczyn, et al.BMC Medicine|May 26, 2017
Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus reportRégis Bordet, Ralf Ihl, Amos D Korczyn, et al.Expert Review of Neurotherapeutics|March 11, 2009
2nd World congress on controversies in neurologyAmos D KorczynCurrent Alzheimer Research|October 3, 2007
Drug trials in dementia: challenging ethical dilemmasAmos D KorczynJournal of Neural Transmission (Vienna, Austria : 1996)|March 20, 2013
Mild cognitive impairment in Parkinson's diseaseAmos D KorczynDialogues in Clinical Neuroscience|October 29, 2011
Drug treatment of Parkinson's diseaseAmos D KorczynPageof 39